Homeostatic proliferation of NK cells: friend or foe in cellular immunotherapy?

被引:0
|
作者
Marek, Natalia [1 ]
Trzonkowski, Piotr [1 ]
机构
[1] Univ Gdansk, Dept Clin Immunol & Transplantol Med, PL-80952 Gdansk, Poland
关键词
homeostatic proliferation; long-lived NK cells; long-term innate immunity; NK cells; viral immunity; T-CELLS; CD4(+); NAIVE; PHENOTYPE;
D O I
10.2217/IMT.11.53
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Evaluation of: Sun JC, Beilke JN, Bezman NA, Lanier LL: Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection. J. Exp. Med. 208(2), 357-368 (2011). NK cells are an important tool in cellular immunotherapy owing to their role in infections and antitumor immunity. Until recently, these cells have been thought to be short-lived cytotoxic effectors that are cleared from the body soon after resolution of an immune response. In the commented study, Sun et al. confirmed that, similar to T cells, NK cells sensed the space in the immune system and underwent homeostatic proliferation in order to provide necessary protection to the body. Moreover, homeostatically driven NK cells persisted in the tissues for a long time without loss of activity. These findings have important consequences for immunotherapy, suggesting that the mechanisms of homeostatic expansion can be deployed in order to expand NK cells for therapeutic purposes in vivo. As homeostatically driven NK cells are long-lived effectors, such therapies can exert prolonged effects for the immunity of the patients.
引用
收藏
页码:727 / 729
页数:3
相关论文
共 50 条
  • [1] NK cells after transplantation: friend or foe
    Hadad, Uzi
    Martinez, Olivia
    Krams, Sheri M.
    [J]. IMMUNOLOGIC RESEARCH, 2014, 58 (2-3) : 259 - 267
  • [2] NK cells after transplantation: friend or foe
    Uzi Hadad
    Olivia Martinez
    Sheri M. Krams
    [J]. Immunologic Research, 2014, 58 : 259 - 267
  • [3] Thermoablation Friend and foe of immunotherapy
    Radosa, Christoph G.
    Hoffmann, Ralf-Thorsten
    [J]. RADIOLOGE, 2020, 60 (08): : 704 - 710
  • [4] Ferroptosis: friend or foe in cancer immunotherapy?
    Demuynck, Robin
    Efimova, Iuliia
    Catanzaro, Elena
    Krysko, Dmitri, V
    [J]. ONCOIMMUNOLOGY, 2023, 12 (01):
  • [5] Friend or Foe: Hidden Dangers of Nivolumab Immunotherapy
    Morim, O.
    Koenig, S. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [6] Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?
    Cong Yan
    Xiao-Xuan Tu
    Wei Wu
    Zhou Tong
    Lu-Lu Liu
    Yi Zheng
    Wei-Qin Jiang
    Peng Zhao
    Wei-Jia Fang
    Hang-Yu Zhang
    [J]. World Journal of Clinical Cases, 2019, (11) : 1253 - 1261
  • [7] Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?
    Yan, Cong
    Tu, Xiao-Xuan
    Wu, Wei
    Tong, Zhou
    Liu, Lu-Lu
    Zheng, Yi
    Jiang, Wei-Qin
    Zhao, Peng
    Fang, Wei-Jia
    Zhang, Hang-Yu
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (11) : 1253 - 1261
  • [8] Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe?
    Jensen, Agnete Witness Praest
    Simoes, Ana Micaela Carnaz
    Straten, Per Thor
    Olofsson, Gitte Holmen
    [J]. CANCERS, 2021, 13 (03) : 1 - 16
  • [9] Chimeric cells; are they a friend or foe?
    Reed, A.
    [J]. JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2006, 71 (02) : 144 - 144
  • [10] Friend of foe? A systematic evaluation of NKT and NK cells as prognostic makers in colorectal carcinoma
    Feng, Hao
    Tong, Huan
    Thasler, Wolfgang
    Xia, Qiang
    [J]. JOURNAL OF IMMUNOLOGY, 2020, 204 (01):